KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other Accumulated Expenses: 2013-2014

Historic Other Accumulated Expenses for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Dec 2014 value amounting to $4.7 million.

  • Biocryst Pharmaceuticals' Other Accumulated Expenses rose 150.46% to $4.7 million in Q4 2014 from the same period last year, while for Dec 2014 it was $4.7 million, marking a year-over-year increase of 150.46%. This contributed to the annual value of $4.7 million for FY2014, which is 150.46% up from last year.
  • Biocryst Pharmaceuticals' Other Accumulated Expenses amounted to $4.7 million in FY2014, which was up 150.46% from $1.9 million recorded in FY2013.
  • Biocryst Pharmaceuticals' Other Accumulated Expenses' 5-year high stood at $4.7 million during FY2014, with a 5-year trough of $1.9 million in FY2013.
  • Moreover, its 2-year median value for Other Accumulated Expenses was $3.3 million (2013), whereas its average is $3.3 million.
  • Data for Biocryst Pharmaceuticals' Other Accumulated Expenses shows a peak YoY surged of 150.46% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Biocryst Pharmaceuticals' Other Accumulated Expenses stood at $1.9 million in 2013, then soared by 150.46% to $4.7 million in 2014.